抗富亮氨酸胶质瘤失活蛋白1抗体相关脑炎临床分析

doi:10.3969/j.issn.1672-6731.2020.09.009

摘要/Abstract

摘要：

目的探讨抗富亮氨酸胶质瘤失活蛋白1（LGI1）抗体相关脑炎的临床特点。方法与结果 2016年9月至2018年4月共诊治6例抗LGI1抗体相关脑炎患者，临床表现为认知功能障碍（6例）、癫发作（4例）、精神行为异常（3例）、睡眠障碍（5例）、自主神经功能障碍（3例），病程中可伴有低钠血症（4例）。脑电图异常较为常见（4例）。头部MRI显示炎症性病变主要累及海马、颞叶内侧（3例）。血清和脑脊液LGI1抗体检测（间接免疫荧光法）双阳性者4例，单纯血清或脑脊液LGI1抗体阳性者分别为6和4例。采用激素和（或）免疫球蛋白治疗，随访6~24个月无一例死亡；其中3例遗留记忆力下降、1例面-臂肌张力障碍发作、2例低钠血症、1例睡眠障碍。。结论抗LGI1抗体相关脑炎以认知功能障碍、癫发作、睡眠障碍、低钠血症为临床特征，对免疫治疗有效，预后相对良好。

关键词: 脑炎, 免疫系统疾病, 认知障碍, 睡眠障碍, 免疫疗法

Abstract:

Objective To explore the clinical characteristics of anti-leucine-rich glioma-inactivated 1 (LGI1) antibody-related encephalitis. Methods and Results Clinical data of 6 patients with anti-LGI1 antibody-related encephalitis from September 2016 to April 2018 were analyzed retrospectively. The clinical manifestations of 6 cases were lognition disorders in 6 cases, seizures in 4 cases, behavioral changes in 3 cases, sleep disorders in 5 cases and autonomic nervous system abnormality in 3 cases. Hyponatremia (4 cases) could be presented. Abnormal EEG (4 cases) was often seen. Brain MRI showed abnormal signals in 3 cases, mainly involved hippocampus and medial temporal lobe. Indirect immunofluorescence assay (IIF) was used to detect anti-LGI1 antibody. Four cases were positive in both serum and cerebrospinal fluid, while 6 cases only in serum and 4 cases only in cerebrospinal fluid. The follow-up results of 6 to 24 months after intravenous hormone or immunoglobulin therapies showed no one died; the sequelae were memory deficit in 3 cases, faciobrachial dystonic seizures in one case, hyponatremia in 2 cases, sleep disorders in one case. Conclusions Anti-LGI1 antibody-related encephalitis is often characterized by cognitive impairment, seizures, sleep disorders and hyponatremia. Immunotherapy is effective, which has good prognosis comparatively.

Key words: Encephalitis, Immune system diseases, Cognition disorders, Sleep disorders, Immunotherapy

赵清青, 戴淑娟, 艾明达, 陈玲, 艾青龙. 抗富亮氨酸胶质瘤失活蛋白1抗体相关脑炎临床分析[J]. 中国现代神经疾病杂志, 2020, 20(9): 806-812.

ZHAO Qing-qing, DAI Shu-juan, AI Ming-da, CHEN Ling, AI Qing-long. Clinical analysis of anti-leucine-rich glioma-inactivated 1 antibody-related encephalitis[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2020, 20(9): 806-812.

https://journal11.magtechjournal.com/cjcnn/CN/Y2020/V20/I9/806

参考文献

[1] Steriade C, Mirsattari SM, Murray BJ, Wennberg R. Subclinical in LGI1-antibody-mediated encephalitis[J]. Epilepsia, 2016, 57:155-160.
[2] Dalmau J, Graus F. Antibody-mediated encephalitis[J]. N Engl J Med, 2018, 378:840-851.
[3] Lai M, Huijbers MG, Lancaster E, Graus PF, Bataller L, Balice-Gordon PR, Cowell PJ, Dalmau PJ. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels:a case series[J]. Lancet Neurol, 2010, 9:776-785.
[4] Jin LR, Liu Q, Ren HT, Guan HZ, Zheng JB, Cui RX, Wu LW, Yang YC, Cui LY. Clinical characteristics of one patient with leucine-rich glioma inactivated-1 antibody positive limbic encephalitis[J]. Zhonghua Shen Jing Ke Za Zhi, 2013, 46:461-464.[金丽日, 柳青, 任海涛, 关鸿志, 郑建彪, 崔瑞雪, 吴立文, 杨荫昌, 崔丽英. 富亮氨酸胶质瘤失活1蛋白抗体阳性边缘系统脑炎一例临床特点[J].中华神经科杂志, 2013, 46:461-464.]
[5] Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Hoftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Pruss H, Dalmau J. A clinical approach to diagnosis of autoimmune encephalitis[J]. Lancet Neurol, 2016, 15:391-404.
[6] Neurology Branch, Chinese Medical Association. Expert consensus on diagnosis and treatment of autoimmune encephalitis in China[J]. Zhonghua Shen Jing Ke Za Zhi, 2017, 50:91-98.[中华医学会神经病学分会. 中国自身免疫性脑炎诊治专家共识[J]. 中华神经科杂志, 2017, 50:91-98.]
[7] Day GS. Rethinking outcomes in leucine-rich, glioma-inactivated 1 protein encephalitis:"good" isn't good enough[J]. JAMA Neurol, 2017, 74:19-21.
[8] Aurangzeb S, Symmonds M, Knight RK, Kennett R, Wehner T, Irani SR. LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures[J]. Seizure, 2017, 50:14-17.
[9] Lu Q, Guan HZ, Liu Q, Huang Y, Jin LR, Zhou XQ, Cui LY. Clinical seizure fea tures and EEG pattern in patients with anti-leucine-rich gliomainactivated 1 antibody-associated encephalitis[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2018, 18:331-335.[卢强, 关鸿志, 柳青, 黄颜, 金丽日, 周祥琴, 崔丽英. 抗富亮氨酸胶质瘤失活基因1抗体相关脑炎癫发作和脑电图特征[J]. 中国现代神经疾病杂志, 2018, 18:331-335.]
[10] Van SA, Thijs RD, Coenders EC, Jiskoot LC, Sanchez E, De Bruijn M, Van MH, Wirtz PW, Schreurs MW, Sillevis Smitt P, Titulaer MJ. Anti-LGI1 encephalitis:clinical syndrome and long-term follow-up[J]. Neurology, 2016, 87:1449-1456.
[11] Zhao QQ, Geng J, Ai QL. The clinical research progress of anti-leucine-rich glioma-inactivated 1 antibody-associated encephalitis[J]. Zhongguo Shen Jing Jing Shen Ji Bing Za Zhi, 2018, 44:753-756.[赵清青, 耿嘉, 艾青龙. 抗富亮氨酸胶质瘤失活蛋白1抗体相关脑炎的临床研究进展[J]. 中国神经精神疾病杂志, 2018, 44:753-756.]
[12] Jang Y, Lee ST, Lim JA, Kim TJ, Jun JS, Moon J, Sunwoo JS, Jung KH, Park KI, Jung KY, Kim M, Lee SK, Chu K. Psychiatric symptoms delay the diagnosis of anti-LGI1 encephalitis[J]. J Neuroimmunol, 2018, 317:8-14.
[13] Hayashi Y, Yamada M, Kimura A, Inuzuka T. IVIG treatment for repeated hypothermic attacks associated with LGI1 antibody encephalitis[J]. Neurol Neuroimmunol Neuroinflamm, 2017, 4:E348.
[14] Irani SR, Lehmann-Horn K, Geschwind M, Wang S, Vincent A, Budingen HC. The active intrathecal B-cell response in LGI1-antibody encephalitis[J]. Lancet, 2015, 385:S46.
[15] Tripathi M, Tripathi M, Roy SG, Parida GK, Ihtisham K, Dash D, Damle N, Shamim SA, Bal C. Metabolic topography of autoimmune non-paraneoplastic encephalitis[J]. Neuroradiology, 2018, 60:189-198.
[16] Guan HZ, Xu XL, Zhu YC, Wang F, Fan XY, Huang Y, Jin LR, Lu Q, Ren HT, Xu Y, Peng B, Cui LY. Clinical and immunological analysis of mycophenolate mofetil treatment in anti-leucine-rich glioma-inactivated 1 encephalitis[J]. Zhonghua Shen Jing Ke Za Zhi, 2018, 51:281-287.[关鸿志, 徐晓璐, 朱以诚, 王斐, 范思远, 黄颜, 金丽日, 卢强, 任海涛, 徐雁, 彭斌, 崔丽英. 吗替麦考酚酯治疗抗富亮氨酸胶质瘤失活蛋白1脑炎的临床与免疫参数观察[J]. 中华神经科杂志, 2018, 51:281-287.]

选择文件类型/文献管理软件名称

选择包含的内容

2 抗富亮氨酸胶质瘤失活蛋白1抗体相关脑炎临床分析

Clinical analysis of anti-leucine-rich glioma-inactivated 1 antibody-related encephalitis

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	许鸿嘉, 舒崖清, 王蘋, 李蕃, 许顺良, 邱伟, 马晓宇. 抗水通道蛋白4抗体阳性视神经脊髓炎谱系疾病诊断与治疗进展[J]. 中国现代神经疾病杂志, 2024, 24(5): 308-314.
[2]	黄瑀, 廖金池, 舒崖清. 抗N-甲基-D-天冬氨酸受体脑炎睡眠障碍研究进展[J]. 中国现代神经疾病杂志, 2024, 24(5): 315-319.
[3]	刘彩云, 金涛. 树突状细胞在多发性硬化免疫治疗中的应用[J]. 中国现代神经疾病杂志, 2024, 24(5): 320-330.
[4]	叶睿曦, 蔡林君, 孔雪莹, 李劲梅, 周东, 洪桢. 抗N-甲基-D-天冬氨酸受体脑炎急性期严重程度及短期预后影响因素分析[J]. 中国现代神经疾病杂志, 2024, 24(5): 331-339.
[5]	秦红玲, 李启慧, 卢意, 邱伟, 舒崖清. 抗接触蛋白相关蛋白-2抗体相关脑炎临床特征分析[J]. 中国现代神经疾病杂志, 2024, 24(5): 340-345.
[6]	李萍, 徐艳芳, 胡帅, 曾晓霞, 胡娟娟, 漆学良. 热射病致吉兰-巴雷综合征三例并文献复习[J]. 中国现代神经疾病杂志, 2024, 24(5): 352-358.
[7]	程婧, 张炜炜, 周勤明, 孟环宇, 何璐, 陈晟. 抗神经丝重链抗体相关脑炎一例并文献复习[J]. 中国现代神经疾病杂志, 2024, 24(5): 359-364.
[8]	王晓娟, 蒋玙舒, 秦灵芝, 张弥兰, 王佳伟, 李玮. 人类伪狂犬病毒感染性脑炎的诊断与治疗[J]. 中国现代神经疾病杂志, 2024, 24(4): 203-207.
[9]	何晓燕, 王姗姗, 李红燕. 感染相关性自身免疫性脑炎临床特征分析[J]. 中国现代神经疾病杂志, 2024, 24(4): 208-216.
[10]	彭玉晶, 史晓红, 王佳伟. 伴脑膜炎和（或）脑炎的Vogt-小柳-原田综合征临床特征分析[J]. 中国现代神经疾病杂志, 2024, 24(4): 217-223.
[11]	徐坤榕, 王晓娟, 张弥兰, 薛红飞, 徐佳佳, 李玮. 单纯疱疹病毒1型脑炎临床特点及预后影响因素分析[J]. 中国现代神经疾病杂志, 2024, 24(4): 224-229.
[12]	武进, 郝小军, 关鸿志, 郭雅坤. 新型冠状病毒相关副感染性脑病三例[J]. 中国现代神经疾病杂志, 2024, 24(4): 238-244.
[13]	徐金梅, 刘兵舰, 关鸿志, 单萍, 陈国华, 梅俊华. 重度发热伴血小板减少综合征脑炎一例[J]. 中国现代神经疾病杂志, 2024, 24(4): 253-257.
[14]	龚梦茜, 孙迎迎, 徐传英, 张伟, 祖洁, 崔桂云. 血清8-羟基脱氧鸟苷和丙二醛与帕金森病认知功能障碍的相关分析[J]. 中国现代神经疾病杂志, 2024, 24(3): 164-170.
[15]	姬莉, 杨宁, 刘卫国, 牛程麟. 老年帕金森病患者自主神经功能与认知功能的相关分析[J]. 中国现代神经疾病杂志, 2024, 24(3): 171-176.

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

2 抗富亮氨酸胶质瘤失活蛋白1抗体相关脑炎临床分析

Clinical analysis of anti-leucine-rich glioma-inactivated 1 antibody-related encephalitis

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价